NIMENRIX

Google image searchProduct monograph

Active ingredients

meningococcal polysaccharide antigen group a, 5 MCG/0.5 ML

meningococcal polysaccharide antigen group c, 5 MCG/0.5 ML

meningococcal polysaccharide antigen group w-135, 5 MCG/0.5 ML

meningococcal polysaccharide antigen group y, 5 MCG/0.5 ML

tetanus toxoid, 44 MCG/0.5 ML

DIN: 02402904

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAMUSCULAR

Description: SINGLE-DOSE VIAL WITH DILUENT (0.5ML IN A PREFILLED-SYRINGE). 1 & 10 KITS

Schedule: Schedule D

Company: PFIZER CANADA ULC

Date: 17-MAY-2017

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
• J07AH — Meningococcal vaccines (ATC, ATC/DDD)
• J07AH04 — MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN (ATC/DDD)

Reference brand drug: Nimenrix

External Links for Nimenrix

Search on Google

• Nimenrix side effects
• Nimenrix dosage
• meningococcal polysaccharide antigen group a side effects
• meningococcal polysaccharide antigen group a dosage
• meningococcal polysaccharide antigen group c side effects
• meningococcal polysaccharide antigen group c dosage
• meningococcal polysaccharide antigen group w-135 side effects
• meningococcal polysaccharide antigen group w-135 dosage
• meningococcal polysaccharide antigen group y side effects
• meningococcal polysaccharide antigen group y dosage
• tetanus toxoid side effects
• tetanus toxoid dosage